News

Original Article Archive Bronchodilators and Corticosteroids in the Treatment of Obstructive Pulmonary Emphysema Authors: William Franklin, M.D., A. L.
Bronchodilators don’t improve smoking-related respiratory symptoms in people without COPD About 20–40% of adults with COPD symptoms but who aren’t diagnosed with COPD use these types of long ...
Researchers supported by the National Institutes of Health have found that dual bronchodilators - long-lasting inhalers that relax the airways and make it easier to breathe - do little to help ...
Source Reference: Sin DD "RETHINCking COPD -- bronchodilators for symptomatic tobacco-exposed persons with preserved lung function?" N Engl J Med 2022; DOI: 10.1056/NEJMe2210347.
The Bottom Line "In patients with risk factors for COPD and respiratory symptoms, referring for spirometry is important to triage who will and won’t benefit from bronchodilators." – Meilan Han ...
Inhaled dual bronchodilator therapy did not decrease respiratory symptoms among individuals who were current or former smokers and had respiratory symptoms but preserved lung function without COPD ...
Bronchodilators combining the active ingredients of both anticholinergic and beta-agonist bronchodilators appear headed toward FDA approval. What will be the benefits of this new device?
A study of older patients with COPD suggests that new use of the long-acting bronchodilators β-agonists and anticholinergics was associated with similar increased risks of cardiovascular events.
Bronchodilators Market Size, Share & Trends Analysis Report By Disease (Asthma, COPD), By Route Of Administration (Inhalable, Oral), By Drug Class (Beta-Adrenergic, Anticholinergics), By Region ...
The demand for bronchodilators is growing significantly, owing to the increasing incidence of respiratory disorders. The surging number of smokers is increasing the population with a heightened risk ...
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function. New England Journal of Medicine, 2022; DOI: 10.1056/NEJMoa2204752 ...